184 related articles for article (PubMed ID: 22749963)
1. Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability.
Zhang J; Ouyang W; Li J; Zhang D; Yu Y; Wang Y; Li X; Huang C
Toxicol Appl Pharmacol; 2012 Sep; 263(2):218-24. PubMed ID: 22749963
[TBL] [Abstract][Full Text] [Related]
2. Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells.
Kawamata N; Chen J; Koeffler HP
Blood; 2007 Oct; 110(7):2667-73. PubMed ID: 17606765
[TBL] [Abstract][Full Text] [Related]
3. Isorhapontigenin (ISO) inhibited cell transformation by inducing G0/G1 phase arrest via increasing MKP-1 mRNA Stability.
Gao G; Chen L; Li J; Zhang D; Fang Y; Huang H; Chen X; Huang C
Oncotarget; 2014 May; 5(9):2664-77. PubMed ID: 24797581
[TBL] [Abstract][Full Text] [Related]
4. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.
Jin JS; Tsao TY; Sun PC; Yu CP; Tzao C
Pathol Oncol Res; 2012 Jul; 18(3):713-20. PubMed ID: 22270866
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
6. GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription.
Lin S; Huang HC; Chen LL; Lee CC; Huang TS
Mol Pharmacol; 2001 Oct; 60(4):768-75. PubMed ID: 11562439
[TBL] [Abstract][Full Text] [Related]
7. NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells.
Pai JT; Hsu CY; Hua KT; Yu SY; Huang CY; Chen CN; Liao CH; Weng MS
Molecules; 2015 May; 20(5):8000-19. PubMed ID: 25946558
[TBL] [Abstract][Full Text] [Related]
8. SOX7 is involved in polyphyllin D-induced G0/G1 cell cycle arrest through down-regulation of cyclin D1.
Zheng B; Wang G; Gao W; Wu Q; Zhu W; Weng G
Acta Pharm; 2020 Jun; 70(2):191-200. PubMed ID: 31955140
[TBL] [Abstract][Full Text] [Related]
9. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro.
Seewaldt VL; Kim JH; Parker MB; Dietze EC; Srinivasan KV; Caldwell LE
Exp Cell Res; 1999 May; 249(1):70-85. PubMed ID: 10328955
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells.
Saikawa Y; Kubota T; Otani Y; Kitajima M; Modlin IM
Jpn J Cancer Res; 2001 Oct; 92(10):1102-9. PubMed ID: 11676861
[TBL] [Abstract][Full Text] [Related]
12. GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells.
Liu SL; Liu Z; Zhang LD; Zhu HQ; Guo JH; Zhao M; Wu YL; Liu F; Gao FH
Cell Cycle; 2017; 16(24):2386-2395. PubMed ID: 28980866
[TBL] [Abstract][Full Text] [Related]
13. Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells.
Sun PC; Tzao C; Chen BH; Liu CW; Yu CP; Jin JS
J Biomed Sci; 2010 Sep; 17(1):76. PubMed ID: 20846458
[TBL] [Abstract][Full Text] [Related]
14. The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases.
Tabruyn SP; Nguyen NQ; Cornet AM; Martial JA; Struman I
Mol Endocrinol; 2005 Jul; 19(7):1932-42. PubMed ID: 15746189
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.
Carlson B; Lahusen T; Singh S; Loaiza-Perez A; Worland PJ; Pestell R; Albanese C; Sausville EA; Senderowicz AM
Cancer Res; 1999 Sep; 59(18):4634-41. PubMed ID: 10493518
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover.
Lin S; Wang W; Wilson GM; Yang X; Brewer G; Holbrook NJ; Gorospe M
Mol Cell Biol; 2000 Nov; 20(21):7903-13. PubMed ID: 11027261
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.
Das SK; Hashimoto T; Kanazawa K
Biochim Biophys Acta; 2008 Apr; 1780(4):743-9. PubMed ID: 18230364
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.
Takuwa N; Fukui Y; Takuwa Y
Mol Cell Biol; 1999 Feb; 19(2):1346-58. PubMed ID: 9891068
[TBL] [Abstract][Full Text] [Related]
19. Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.
Ouyang W; Zhang D; Li J; Verma UN; Costa M; Huang C
J Cell Physiol; 2009 Jan; 218(1):205-14. PubMed ID: 18792914
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells.
Dufourny B; van Teeffelen HA ; Hamelers IH; Sussenbach JS; Steenbergh PH
J Endocrinol; 2000 Aug; 166(2):329-38. PubMed ID: 10927622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
